☆ 4.3 Letter

Maximally tolerated versus minimally effective dose: the case of rituximab in multiple sclerosis

MULTIPLE SCLEROSIS JOURNAL (2012)

Journal

MULTIPLE SCLEROSIS JOURNAL

Volume 18, Issue 3, Pages 377-378

Publisher

SAGE PUBLICATIONS LTD

DOI: 10.1177/1352458511418631

Keywords

-

Categories

Clinical Neurology Neurosciences

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.